Redcare Pharmacy raises 2026 revenue guidance again on strong Germany Rx momentum
Company now expects 2026 total revenue growth of 16% to 18%, from 15% to 17%. Germany Rx revenue now seen at a higher range, with adjusted EBITDA margin unchanged at 2.5% to 3.0%.